(Q34621057)

3 August 2017

title

Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients (English)

1 reference

3 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1984.TB02338.X

28 September 2023

author name string

C. Richer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6324834

28 September 2023

B. Giroux

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6324834

28 September 2023

P. F. Plouin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6324834

28 September 2023

B. Maarek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6324834

28 September 2023

J. F. Giudicelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6324834

28 September 2023

language of work or name

English

0 references

publication date

1 March 1984

1 reference

full work available at URL

3 August 2017

https://europepmc.org/articles/pmc1463370?pdf=render

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6324834

https://europepmc.org/articles/PMC1463370

28 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6324834

https://europepmc.org/articles/PMC1463370?pdf=render

28 September 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6324834

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1984.tb02338.x

28 September 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1984.TB02338.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1984.tb02338.x/fullpdf

28 September 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1984.TB02338.X

British Journal of Clinical Pharmacology

28 September 2023

published in

1 reference

3 August 2017

volume

17

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

243-250

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463370

3 August 2017

1 reference

Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations.

7 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463370

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521

7 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463370

Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension

7 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463370

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects

7 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1984.TB02338.X

Hypertension management: the computer as a participant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1984.TB02338.X

Pharmacokinetic properties of captopril after acute and chronic administration to hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1984.TB02338.X

Disposition of captopril in normal subjects

21 January 2018

1 reference

12 December 2020

Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril

1 reference

12 December 2020

The measurement of angiotensin-converting enzyme in subjects receiving captopril

1 reference

12 December 2020

Low temperature sustains inhibition of angiotensin-converting-enzyme activity in serum from patients taking captopril

1 reference

12 December 2020

Captopril combined with thiazide lowers renin substrate concentration: implications for methodology in renin assays

1 reference

12 December 2020

High-performance liquid chromatographic analysis of captopril in plasma

1 reference

12 December 2020

Determination of captopril in blood and urine by high-performance liquid chromatography

1 reference

12 December 2020

ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421"

1 reference

12 December 2020

Blood concentration and urinary excretion of captopril (SQ 14,225) in patients with chronic renal failure

1 reference

12 December 2020

Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1984.TB02338.X

28 September 2023

Identifiers

1 reference

3 August 2017

1 reference

3 August 2017

1 reference